Dr. Salvatore Dimercurio, MD

Dr. Dimercurio practices at Meritus Medical Laboratory - Meritus Medical Plaza, Hagerstown in Hagerstown, Maryland.

Dr. Dimercurio's NPI, 1578505798, was assigned on June 12, 2006. Dr. Dimercurio graduated from Icahn School Of Medicine At Mount Sinai in 1984. Dr. Dimercurio holds Maryland license D0043541.

Dr. Dimercurio's primary practice is Meritus Medical Laboratory - Meritus Medical Plaza, Hagerstown, at 11110 Medical Campus Rd, Hagerstown, MD 21742. The practice phone is (301) 790-8624.

Dr. Dimercurio's primary practice is Meritus Medical Laboratory - Meritus Medical Plaza, Hagerstown in Hagerstown, Maryland. Dr. Dimercurio is also affiliated with Meritus Medical Center. The medical group on file is Meritus Robinwood Orthopedics. Dmand AI also links Dr. Dimercurio to 1 more hospital, 1 physician office and 1 group practice or clinic, each named with a free account. Dr. Dimercurio's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dimercurio practices, 5 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Dimercurio's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dr. Dimercurio is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Dimercurio's licenses on file in 3 states: Maryland, Pennsylvania and West Virginia.

Dmand AI lists breast reconstruction, breast surgery and cancerous skin growth removal among the conditions Dr. Dimercurio treats.

CMS data shows 468 Medicare services from Dr. Dimercurio across 7 procedure codes in 2024, for 205 Medicare patients. Medicare paid $25,092 for them. Every service was in an office.

CMS counts 205 Medicare patients who saw Dr. Dimercurio in 2024. The largest group is 65 to 74, with 90 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dimercurio's median patient age at 68, with 63% women.

In 2024, Dr. Dimercurio wrote 155 Medicare Part D claims for 65 patients. 93% of them were for generic drugs. CMS names the drug for 105 of them, across 4 drugs with 11 or more claims each, at $164 in total drug cost. In 2023, CMS named 128 claims across 5 drugs.

Dr. Dimercurio accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 45 procedures of melanoma (skin cancer) excision by Dr. Dimercurio, more than 85% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Dimercurio to 1 clinical trial.

CMS Open Payments shows 71 general payments to Dr. Dimercurio from 16 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 58% of the total. Lifecell Corporation paid the most, $2,072.

Dmand AI lists 1 award for Dr. Dimercurio, most recently President in 2010.

Dr. Dimercurio graduated from Icahn School Of Medicine At Mount Sinai in 1984. Dr. Dimercurio is a member of ASPS.

Dr. Dimercurio is in network with 22 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Highmark. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.